Author Archive: BIOtechNOW Editor

Interstitial Cystitis: Understanding What It Is, and the Interstitial Cystitis Association’s Role in an IC Patient’s Life

scientist, lab

If you mention Interstitial Cystitis (IC) to most people, including physicians, the majority of people have no idea what you are talking about. This is alarming because IC affects between 4-12 million people, just in the U.S. alone.  The majority of IC patients are women, but both men and children can receive the diagnosis as well.  So what is IC and how do you know if you have it? Interstitial cystitis (in-ter-stish-uhl sĭ-stī’tĭs), or as Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post

Expect A Hard Winter for Honey Bees


There’s nothing I enjoy more than getting out in the field and investigating honey bee colonies.  All right, maybe there are a few things I enjoy more, but I consider it a “win” any time I get out of the office to work with bees!  During these late summer and early fall inspections, which involve evaluating up to a hundred and fifty samples taken from different hives across the country, I’ve gotten pretty good at Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

The Liquid Gold Rush For Biopsies

Liquid biopsy is considered “liquid gold”. Estimates the global testing market to reach $20 billion by 2020.

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post

Check Out This Op-Ed from PA Bio

Make sure to check out the op-ed that Christopher P. Molineaux, President and CEO of Pennsylvania Bio, has written. The piece, entitled Here’s why the insurance industry needs to do its part to keep healthcare costs down, does an outstanding job laying out the important role that biotechnology plays in reducing long-term health care costs and what must be done to ensure that patients have access to the next generation of medical innovations. As Molineaux Read More >

Health  |  Leave a comment  |  Email This Post

Setting the Record Straight on Innovation and Drug Development


Modern biotechnology is a relatively young industry, but in just over 40 years, the entrepreneurs, researchers and investors working in this field have firmly established themselves at the forefront of medical innovation and the search for new cures and therapies for previously untreatable diseases. That’s why it is important that policy proposals designed to respond to the activities of outliers like Turing Pharmaceuticals and Valeant do not hurt America’s leadership in biotechnology innovation and investment. Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,